Ca
Caris Life Sci
Irving TXFounded 20082,000 employees
Private CapbiotechPrivateOncology
Platform: Molecular Prof
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CAR-3300 | CAR-3300 | Approved | 1 | FXIa | Bladder CaFL | ||
| Pexaderotide | CAR-2685 | Phase 3 | 4 | PARP | PNHCholangiocarcinoma | ||
| CAR-9528 | CAR-9528 | Preclinical | 2 | SOS1 | PompeRA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)